ACCOUNTS - Final Accounts


Caseware UK (AP4) 2016.0.181 2016.0.181 2017-09-302017-09-30The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.truefalseNo description of principal activityfalse2016-10-01Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan. Investments in non-derivative instruments that are equity to the issuer are measured: at fair value with changes recognised in the Statement of income and retained earnings if the shares are publicly traded or their fair value can otherwise be measured reliably; at cost less impairment for all other investments. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of income and retained earnings. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date. Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. 07159574 2016-10-01 2017-09-30 07159574 2015-10-01 2016-09-30 07159574 2017-09-30 07159574 2016-09-30 07159574 c:Director1 2016-10-01 2017-09-30 07159574 d:CurrentFinancialInstruments 2017-09-30 07159574 d:CurrentFinancialInstruments 2016-09-30 07159574 d:CurrentFinancialInstruments d:WithinOneYear 2017-09-30 07159574 d:CurrentFinancialInstruments d:WithinOneYear 2016-09-30 07159574 d:ShareCapital 2017-09-30 07159574 d:ShareCapital 2016-09-30 07159574 d:SharePremium 2017-09-30 07159574 d:SharePremium 2016-09-30 07159574 d:RetainedEarningsAccumulatedLosses 2017-09-30 07159574 d:RetainedEarningsAccumulatedLosses 2016-09-30 07159574 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2017-09-30 07159574 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2016-09-30 07159574 c:FRS102 2016-10-01 2017-09-30 07159574 c:AuditExempt-NoAccountantsReport 2016-10-01 2017-09-30 07159574 c:FullAccounts 2016-10-01 2017-09-30 07159574 c:PrivateLimitedCompanyLtd 2016-10-01 2017-09-30 iso4217:GBP xbrli:pure

Registered number: 07159574









ADROIT TREATMENT SYSTEMS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2017

 
ADROIT TREATMENT SYSTEMS LIMITED
REGISTERED NUMBER: 07159574

BALANCE SHEET
AS AT 30 SEPTEMBER 2017

2017
2016
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
9,060
36,092

Cash at bank and in hand
 5 
8,309
137

  
17,369
36,229

Creditors: amounts falling due within one year
 6 
(17,673)
(33,997)

Net current (liabilities)/assets
  
 
 
(304)
 
 
2,232

Total assets less current liabilities
  
(304)
2,232

  

Net (liabilities)/assets
  
(304)
2,232


Capital and reserves
  

Called up share capital 
  
10,000
10,000

Share premium account
  
15,000
15,000

Profit and loss account
  
(25,304)
(22,768)

  
(304)
2,232


Page 1

 
ADROIT TREATMENT SYSTEMS LIMITED
REGISTERED NUMBER: 07159574
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2017

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 13 September 2018.




S M Crickley
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
ADROIT TREATMENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017

1.


General information

Adroit Treatment Systems Limited is a private limited company limited by share capital. The company is registered in England and Wales, company number 07159574 with registered office located at 1 The Green, Richmond, Surrey TW9 1PL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The director is currently considering options available for thefuture of the company. Currently support is being provided to the company to continue for the foreseeable future. The accounts have therefore been prepared on the basis that the company remains a going concern.

 
2.3

Interest income

Interest income is recognised in the Statement of income and retained earnings using the effective interest method.

 
2.4

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that
Page 3

 
ADROIT TREATMENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017

2.Accounting policies (continued)


2.7
Financial instruments (continued)

are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Investments in non-derivative instruments that are equity to the issuer are measured:
at fair value with changes recognised in the Statement of income and retained earnings if the shares are publicly traded or their fair value can otherwise be measured reliably;
at cost less impairment for all other investments.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of income and retained earnings.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The Company has no employees other than the directors, who did not receive any remuneration (2016 - £NIL).

The average monthly number of employees, including directors, during the year was 0 (2016 - 0).


4.


Debtors

2017
2016
£
£


Tax recoverable
9,060
36,092
Page 4

 
ADROIT TREATMENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017

4.Debtors (continued)


9,060
36,092



5.


Cash and cash equivalents

2017
2016
£
£

Cash at bank and in hand
8,309
137

8,309
137



6.


Creditors: Amounts falling due within one year

2017
2016
£
£

Trade creditors
15,000
12,928

Amounts owed to group undertakings
537
537

Other taxation and social security
1,286
1,832

Accruals and deferred income
850
18,700

17,673
33,997



7.


Financial instruments

2017
2016
£
£

Financial assets


Financial assets measured at fair value through profit or loss
8,309
137




Page 5

 
ADROIT TREATMENT SYSTEMS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017

8.


First time adoption of FRS 102

The policies applied under the entity's previous accounting framework are not materially different to FRS 102 and have not impacted on equity or profit or loss.

 
Page 6